Hydrazine (antidepressant)

The hydrazine antidepressants are a group of non-selective, irreversible monoamine oxidase inhibitors (MAOIs) which were discovered and initially marketed in the 1950s and 1960s. Most have been withdrawn due to toxicity, namely hepatotoxicity, but a few still remain in clinical use.

This article is about a series of antidepressants. For the toxic, unstable compound with the chemical formula N2H4, see hydrazine.
Iproniazid, the first hydrazine MAOI to be discovered.

Tranylcypromine, a structurally unrelated MAOI introduced around the same time as the hydrazines, was originally advertised as non-hydrazine as a result of its diminished propensity for causing hepatotoxicity.

List of hydrazine antidepressants

Marketed

Legend: ‡ = Withdrawn from the market; † = Partially discontinued; Bolded names indicate major drugs.

Never marketed

Parkinson's

Tranquillosedative
  • Centazolone

References
    • López-Muñoz F, Alamo C (2009). "Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today". Current Pharmaceutical Design. 15 (14): 1563–86. doi:10.2174/138161209788168001. PMID 19442174. Archived from the original on 2013-04-14.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.